[ad_1]
Immunotherapy can "dramatically" mitigate the effects of bad cancer. In fact, some women have achieved with this treatment a survival of more than two and a half years with a good quality of life, badured Chilean experts of the treatment of this disease.
"In fact, there are cases whose life expectancy was four to six months and after being treated with third-generation dendritic cell immunotherapy, their survival was greater than two and a half years with a good quality Ramón Gutiérrez, pathologist and stressed molecular oncologist
He explains that for almost all types of cancer, there are different procedures, including traditional procedures such as surgery, chemotherapy and radiotherapy.
It is also more and more common to attack this disease with complementary treatments such as immunotherapy, which can even be used in patients with advanced cancer, the only treatment option to increase its survival until 325%.
"In our country, with the support of the public development company (CORFO), the Chilean company BioGénica and from Clínica ReCell, we have developed an advanced biotechnology. applied in the treatment of personalized immunotherapy for oncological diseases – unique in Latin America – "said the professional.
" The natural defenses of the body are stimulated in order to fight the disease, to using cells and molecules produced by the body, to improve or restore the functioning of the immune system, "he explained.
In Chile and around the world, bad cancer is the the leading cause of death among women, and while in the world a woman dies every minute because of this disease, in our country, three people die every day.
Dr. Gutiérrez, director of Recell, said At Efe that immunotherapy with dendritic cells is a personalized biological therapy that is made from the patient's own blood cells and tumor molecules (from a recent or elderly biopsy) programmed into thelaboratory then reintegrated into the body on an outpatient basis.
"This type of treatment can: stop or delay the growth of cancer cells, prevent them from branching out to other parts of the body, reduce the complications of cancer and even allow the reevaluation of surgical treatments initially judged Unworkable "
According to Gutiérrez, in patients who get an answer, immunotherapy can reduce the recurrence of cancer by up to 70% and boost up to 40%.
The specialist noted that they had "developed treatments for patients receiving only palliative management because they were terminally ill, and 50 days after the end of the treatment protocol, there was no cure". 39 to 40% of the metabolic activity of the tumor and even the disappearance of 30% of the tumor mbad. "
" However, "warns Dr. Gutiérrez," each case is different ".
70% may decrease immunotherapy during the recurrence of cancer
"We achieved third-generation dendritic cell immunotherapy, which is 10 to 20 times more effective than the other versions even supplemented by an innovative module of exosomes, "said the specialist. 19659002] According to the professional, for the patient, the important thing is to identify an immunotherapy protocol with support and to give the highest possible efficiency, which always requires tumor and blood sample.
"Then comes the laboratory phase of" third generation "which carries out for two months the molecular programming necessary for the greatest therapeutic effectiveness, avoiding undesirable reactions," he concluded.
Mama Cancer Month
The month of October is Breast Cancer Awareness Month and specifically on the 19th of this month, her day is commemorated on the scale international.
The figures of this type of cancer show that it is the tumor in the world. more common among women, repeating the same data in Latin America, where this type of cancer accounts for more than 25% of the diseases that women suffer from.
[ad_2]
Source link
